Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Anthropic buys biotech startup Coefficient Bio in $400M deal: reports [TechCrunch]

ROCHE HOLDING LTD S/ADR (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
Company Research Source: TechCrunch
The deal comes as Anthropic continues its push into healthcare and life sciences, following its October announcement of Claude for Life Sciences , a tool that aims to help scientific researchers make discoveries Coefficient Bio's founders, Samuel Stanton and Nathan C. Frey, launched the startup eight months ago, having both worked in computational drug discovery at Genentech's Prescient Design. Coefficient Bio was using AI to help make drug discovery and other forms of biological research more efficient. The team, consisting of around 10 people, is expected to join Anthropic's health and life science team. Subscribe for the industry's biggest tech news Latest in Venture Show less Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RHHBY alerts
Opt-in for
RHHBY alerts

from News Quantified
Opt-in for
RHHBY alerts

from News Quantified